Fieldpoint Private Securities’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$36K Sell
723
-1,721
-70% -$91.3K 0.01% 540
2022
Q1
$125K Buy
2,444
+184
+8% +$9.5K 0.03% 391
2021
Q4
$113K Buy
2,260
+540
+31% +$26.7K 0.02% 422
2021
Q3
$83K Buy
1,720
+280
+19% +$14.2K 0.02% 457
2021
Q2
$73K Buy
1,440
+70
+5% +$3.65K 0.02% 494
2021
Q1
$68K Sell
1,370
-10
-0.7% -$480 0.02% 491
2020
Q4
$67K Sell
1,380
-7,790
-85% -$384K 0.02% 441
2020
Q3
$460K Buy
+9,170
New +$472K 0.14% 172
2020
Q1
Sell
-992
Closed -$50K 511
2019
Q4
$50K Buy
992
+520
+110% +$24.4K 0.01% 435
2019
Q3
$22K Hold
472
0.01% 510
2019
Q2
$20K Buy
+472
New +$20.1K 0.01% 530
2017
Q4
Sell
-637
Closed -$32K 546
2017
Q3
$32K Buy
+637
New +$30.8K 0.01% 444
2017
Q2
Sell
-620
Closed -$28K 301
2017
Q1
$28K Buy
+620
New +$26.3K 0.02% 240

Other funds holding SNY

Fieldpoint Private Securities's SNY Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Sanofi (SNY) stake by 70% in Q2 2022, selling an estimated $91.3K and leaving 723 shares worth $36K. The position accounts for 0.01% of the portfolio, ranked #540.

Fieldpoint Private Securities first reported a position in SNY in Q1 2017 and has held it in 13 quarters since. The position peaked at $460K in Q3 2020. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Fieldpoint Private Securities held 723 shares of Sanofi worth $36K as of Q2 2022.
  • Fieldpoint Private Securities sold 1,721 Sanofi shares in Q2 2022, an estimated $91.3K.
  • Sanofi made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #540 holding.
  • Fieldpoint Private Securities first reported a position in Sanofi in Q1 2017 and has held it in 13 quarters since.
  • Fieldpoint Private Securities's Sanofi position peaked at $460K in Q3 2020.
  • 656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.